Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note published on Sunday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Price Performance

Aethlon Medical stock opened at $0.40 on Friday. The stock has a market capitalization of $5.56 million, a PE ratio of -0.14 and a beta of 1.74. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The business has a 50 day simple moving average of $0.40 and a 200-day simple moving average of $0.43.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.